Results 11 to 20 of about 280,561 (284)

Dexamethasone implant in silicone oil: in vitro behavior [PDF]

open access: yesInternational Journal of Retina and Vitreous, 2018
Background To determine the effect of the silicone on the dexamethasone intravitreal implant. Methods Basic, experimental, prospective and transversal study performed at the hospital “Nuestra Señora de la Luz” in Mexico City.
Erick Omar Flores-Villalobos   +3 more
doaj   +4 more sources

Dexamethasone implant migration into anterior

open access: yesJournal of Retina-Vitreous, 2022
Here, we reported clinical findings, treatment process and complications in a case with the diagnosis of Irvine-Gass syndrome in which intravitreal dexamethasone implant migrated into anterior chamber. Dexamethasone implant (OZURDEX, Allergan) is a safe, effective and easily applicable treatment method which is widely used in the treatment of macular ...
Akaray, İrfan   +2 more
openaire   +3 more sources

Intravitreal Dexamethasone Implant in Autoimmune Retinopathy

open access: yesCase Reports in Ophthalmological Medicine, 2023
Purpose. To describe the results of an intravitreal dexamethasone implant in managing autoimmune retinopathy (AIR). Methods. Two patients affected by AIR underwent intravitreal dexamethasone implantation and were followed by ocular coherence tomography, visual fields, and electroretinography. Results.
Fernando Longhi Bordin   +2 more
openaire   +4 more sources

Dexamethasone implant in retinal vein occlusions

open access: yesClinical Ophthalmology, 2016
Sang Beom Han, Moosang Kim, Seung-Jun Lee Department of Ophthalmology, School of Medicine, Kangwon National University, Chuncheon, South KoreaWe read the article entitled “Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy” by Wallsh et al with great interest.1 The authors ...
Han,Sang Beom   +2 more
openaire   +5 more sources

Hole-in-one: simple non-surgical technique for the management of anterior chamber migrated Ozurdex implant [PDF]

open access: yesGMS Ophthalmology Cases, 2020
Introduction: The migration of a dexamethasone implant to the anterior chamber is a vision-threatening complication which can happen in non-compartmentalized eyes treated with this device.
Rivera-Pérez de Rada, Pablo   +7 more
doaj   +2 more sources

Acute Onset of Exogenous Endophthalmitis after Dexamethasone Implant Injection Treated without Implant Removal

open access: yesCase Reports in Ophthalmological Medicine, 2018
We present a case of acute endophthalmitis after intravitreal dexamethasone implant injection and discuss the management of this rare and challenging case in which the implant could not be removed.
George G. Bastakis   +4 more
doaj   +2 more sources

A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®) [PDF]

open access: yesCase Reports in Ophthalmological Medicine, 2017
Dexamethasone implant, 0,7 mg (Ozurdex, Allergan, Inc., Irvine, CA, USA), is drug mostly used in the treatment of the diabetic macular edema and edema related to retinal vein occlusion.
Erdem Eris   +5 more
doaj   +2 more sources

Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant

open access: yesClinical Ophthalmology, 2010
Jane S Myung, Grant D Aaker, Szilárd KissDepartment of Ophthalmology, Weill Cornell Medical Center, New York, NY, USAPurpose: To report our experience with dexamethasone 0.7 mg sustained-release intravitreal implant (Ozurdex®; Allergan,
Jane S Myung   +2 more
doaj   +2 more sources

Intravitreal Dexamethasone Implant (Ozurdex) in Coats' Disease [PDF]

open access: yesCase Reports in Ophthalmology, 2013
We injected an intravitreal dexamethasone implant in two eyes of 2 pediatric patients with Coats' disease in addition to other treatment modalities, such as intravitreal ranibizumab injection and indirect laser photocoagulation. In both eyes, intraocular pressure moderately rose in a temporary fashion.
SAATCİ, ALİ OSMAN   +2 more
openaire   +5 more sources

Evaluation of efficacy dexamethasone intravitreal implant compared to treatment with anti-VEGF in the treatment of diabetic macular edema

open access: yesSenses and Sciences, 2014
Objective: The study compares the effectiveness of an intravitreal slow-release dexamethasone implant respect to an intravitreal injection of a anti-VEGF, ranibizumab, in the treatment of diabetic macular edema (DME).
Elena Pacella   +8 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy